BPG is committed to discovery and dissemination of knowledge
Featured Articles
6/1/2015 10:01:00 AM | Browse: 745 | Download: 1325
 |
Received |
|
2014-07-25 18:05 |
 |
Peer-Review Started |
|
2014-07-26 13:39 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-10-11 14:56 |
 |
Revised |
|
2014-11-10 03:11 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-12-16 15:29 |
 |
Second Decision by Editor-in-Chief |
|
2014-12-17 03:19 |
 |
Final Decision by Editorial Office Director |
|
2014-12-22 17:04 |
 |
Articles in Press |
|
2014-12-22 17:25 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2015-05-15 19:36 |
 |
Publish the Manuscript Online |
|
2015-05-30 13:32 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Linda S Gutierrez, Jun Ling, Derek Nye, Konstantina Papathomas and Catherine Dickinson |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Institutes of Health |
R15 DK067901-02 |
| Howard Hughes Medical Institute |
52006328 |
| Wilkes Mentoring funds and institutional funds from Wilkes University and TCMC |
|
|
| Corresponding Author |
Linda S Gutierrez, MD, Department of Biology and Health Sciences, Wilkes University, 230 Cohen Science Center, 84 West South Street, Wilkes-Barre, PA 18766, United States. linda.gutierrez@wilkes.edu |
| Key Words |
Thrombospondin 1; ABT-898; ABT-510; Angiogenesis; Inflammatory bowel disease; Dextran sodium sulfate model; Interleukin-6; STAT-3 |
| Core Tip |
Inflammatory bowel disease is still incurable and a major burden in the patient’s life and health care system. The discovery of new and safe therapeutic alternatives is urgently needed. This study tested the efficacy of a new thrombospondin- derived peptide, ABT-898 in a murine model of colitis. Our results indicate that this peptide was able to ameliorate inflammation and angiogenesis. In addition, mice treated with ABT-898 showed significant decrease of plasmatic Interleukin-6 and lesser activation of signal transducer and activator of transcription 3 in colitic lesions. These findings suggest that ABT-898 may indeed be an alternative treatment for inflammatory bowel disease. |
| Publish Date |
2015-05-30 13:32 |
| Citation |
Gutierrez LS, Ling J, Nye D, Papathomas K, Dickinson C. Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model. World J Gastroenterol 2015; 21(20): 6157-6166
|
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i20/6157.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i20.6157 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.